4.73
price up icon20.66%   0.81
pre-market  Pre-mercato:  5.40   0.67   +14.16%
loading

Sonnet Biotherapeutics Holdings Inc Azioni (SONN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
0.0186 0.0373 0.0369 0.0364
Operating Expenses
198.16%
3.8686
1.2975 3.6374 3.9522 5.7012
Benefits Costs and Expenses
0.8217
- - - -
Costs And Expenses
198.16%
3.8686
1.2975 3.6374 3.9522 5.7012
Operating Income/Loss
202.50%
-3.8686
-1.2789 -3.6001 -3.9153 -5.6648
Income/Loss From Continuing Operations Before Tax
131.27%
0.3654
-1.1685 0.0373 0.0369 -5.6671
Income/Loss From Continuing Operations After Tax
131.27%
0.3654
-1.1685 -3.6767 -3.9467 -5.6671
Net Income/Loss
131.27%
0.3654
-1.1685 -3.6767 -3.9467 -5.6671
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
21.59%
4.6177
3.7978 -16.53 29.38 16.51
Diluted Average Shares
28.65%
4.8858
3.7978 -16.53 29.38 -
Basic Earnings Per Share
125.81%
0.08
-0.31 -17.28 -0.13 -0.34
Diluted Earnings Per Share
122.58%
0.07
-0.31 -17.28 -0.13 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.52
price up icon 1.08%
$35.59
price down icon 2.14%
$22.61
price down icon 7.90%
$96.95
price down icon 0.87%
$110.05
price up icon 0.05%
biotechnology ONC
$240.99
price down icon 1.83%
Capitalizzazione:     |  Volume (24 ore):